KRMD (KORU Medical Systems) FFO


KRMD KORU Medical Systems Inc KRMD
76 GF Score
Price $4.49
GF Value $4.08
Valuation Fairly Valued
View Full Analysis

What is KORU Medical Systems FFO?

FFO (Funds from operations) only applies to REITs.

KRMD
76GF Score
KORU Medical Systems Inc KRMD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued. The current stock price of $4.49 is trading 10% above its estimated GF Value™ of $4.08. GuruFocus considers KORU Medical Systems to be Fairly Valued.

Key valuation signals for KRMD:

  • FFO:
  • GF Value™: $4.08 vs. price of $4.49 (10% above fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KORU Medical Systems Business Description

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score

Get the complete analysis for KRMD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.49
Price
$4.08
GF Value